|
|
|
Insider
Information: |
Martin John C |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
2,895,138 |
|
Indirect Shares
|
2,684,281 |
|
|
Direct
Value |
$196,562,487 |
|
|
Indirect Value
|
$49,565,419 |
|
|
Total
Shares |
5,579,419 |
|
|
Total
Value |
$246,127,906 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Director |
2019-02-06 |
2,887,225 |
2016-08-05 |
731,917 |
Premium* |
|
Sarepta Therapeutics Inc |
SRPT |
Director |
2021-03-03 |
7,913 |
2020-02-28 |
0 |
Premium* |
|
Kronos Bio, Inc. |
KRON |
Director |
2020-10-14 |
0 |
2020-10-14 |
1,952,364 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
367 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GILD |
Gilead Sciences Inc |
President and CEO |
|
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
1,553,457 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
1,612,253 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2010-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
1,666,718 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
61,600 |
1,974,363 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2011-03-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
73,920 |
1,986,683 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
2,024,215 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2012-06-29 |
4 |
A |
$29.02 |
$21,271 |
D/D |
733 |
1,989,938 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-01-30 |
5 |
A |
$0.00 |
$0 |
D/D |
78,000 |
4,135,121 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2013-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
106,000 |
4,112,432 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
121,146 |
4,256,267 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-02-14 |
4 |
A |
$21.94 |
$21,243 |
D/D |
968 |
4,257,235 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
360,000 |
4,617,235 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-02-13 |
4 |
A |
$85.61 |
$21,232 |
D/D |
248 |
4,123,235 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
376,846 |
4,500,081 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2015-08-24 |
4 |
A |
$0.00 |
$0 |
I/I |
133,213 |
133,213 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2016-02-15 |
4 |
A |
$76.02 |
$18,854 |
D/D |
248 |
3,948,314 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chairman and CEO |
|
2016-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
194,314 |
4,142,628 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2016-08-05 |
4 |
A |
$0.00 |
$0 |
I/I |
731,917 |
731,917 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
3,131,411 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
20,496 |
3,151,907 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
2,997,106 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Executive Chairman |
|
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
40,010 |
3,037,116 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Director |
|
2019-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
23,250 |
2,901,012 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
5,187 |
5,187 |
0 |
- |
|
KRON |
Kronos Bio, Inc. |
Director |
|
2020-10-14 |
4 |
A |
$0.00 |
$3,314,949 |
I/I |
1,876,564 |
1,876,564 |
0 |
- |
|
367 Records found
|
|
Page 1 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|